Thomas G Wiggans - Net Worth and Insider Trading
Thomas G Wiggans Net Worth
The estimated net worth of Thomas G Wiggans is at least $5 Million dollars as of 2024-03-29. Thomas G Wiggans is the CEO & Chairman of the Board of Dermira Inc and owns about 256,925 shares of Dermira Inc (DERM) stock worth over $5 Million. Thomas G Wiggans is the Director of Jasper Therapeutics Inc and owns about 5,000 shares of Jasper Therapeutics Inc (JSPR) stock worth over $146,800. Thomas G Wiggans is also the CEO of Pardes Biosciences Inc and owns about 50,000 shares of Pardes Biosciences Inc (PRDS) stock worth over $108,000. Details can be seen in Thomas G Wiggans's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas G Wiggans has not made any transactions after 2023-11-28 and currently still holds the listed stock(s).
Transaction Summary of Thomas G Wiggans
Thomas G Wiggans Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas G Wiggans owns 7 companies in total, including Forma Therapeutics Holdings Inc () , Annexon Inc () , and Dermira Inc () among others .
Click here to see the complete history of Thomas G Wiggans’s form 4 insider trades.
Insider Ownership Summary of Thomas G Wiggans
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Forma Therapeutics Holdings Inc | 2020-09-07 | director | |
Annexon Inc | 2020-07-23 | director | |
Dermira Inc | 2020-02-20 | director & CEO & Chairman of the Board | |
Sangamo Therapeutics Inc | 2008-06-04 | director | |
CymaBay Therapeutics Inc | 2022-01-25 | director | |
Pardes Biosciences Inc | 2022-12-05 | director & Chief Executive Officer | |
Jasper Therapeutics Inc | 2023-11-28 | director |
Thomas G Wiggans Latest Holdings Summary
Thomas G Wiggans currently owns a total of 3 stocks. Among these stocks, Thomas G Wiggans owns 256,925 shares of Dermira Inc (DERM) as of August 19, 2019, with a value of $5 Million and a weighting of 94.98%. Thomas G Wiggans owns 5,000 shares of Jasper Therapeutics Inc (JSPR) as of November 28, 2023, with a value of $146,800 and a weighting of 2.89%. Thomas G Wiggans also owns 50,000 shares of Pardes Biosciences Inc (PRDS) as of December 5, 2022, with a value of $108,000 and a weighting of 2.13%.
Latest Holdings of Thomas G Wiggans
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
DERM | Dermira Inc | 2019-08-19 | 256,925 | 18.75 | 4,817,344 |
JSPR | Jasper Therapeutics Inc | 2023-11-28 | 5,000 | 29.36 | 146,800 |
PRDS | Pardes Biosciences Inc | 2022-12-05 | 50,000 | 2.16 | 108,000 |
Holding Weightings of Thomas G Wiggans
Thomas G Wiggans Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas G Wiggans has made a total of 1 transactions in Dermira Inc (DERM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Dermira Inc is the acquisition of 23,419 shares on August 19, 2019, which cost Thomas G Wiggans around $199,998.
According to the SEC Form 4 filings, Thomas G Wiggans has made a total of 3 transactions in Jasper Therapeutics Inc (JSPR) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Jasper Therapeutics Inc is the acquisition of 1,000 shares on November 28, 2023, which cost Thomas G Wiggans around $6,500.
According to the SEC Form 4 filings, Thomas G Wiggans has made a total of 2 transactions in Pardes Biosciences Inc (PRDS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Pardes Biosciences Inc is the acquisition of 12,500 shares on December 5, 2022, which cost Thomas G Wiggans around $13,625.
Insider Trading History of Thomas G Wiggans
- 1
Thomas G Wiggans Trading Performance
GuruFocus tracks the stock performance after each of Thomas G Wiggans's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas G Wiggans is 73.92%. GuruFocus also compares Thomas G Wiggans's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas G Wiggans within 3 months outperforms 8 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas G Wiggans's insider trading performs compared to the benchmark.
Performance of Thomas G Wiggans
Average Relative Return
-3.89%
Outperforming Transactions
25%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Relative Return(%) | 12.65 | 73.92 | 25.64 | -3.89 | ||
Relative Return to S&P 500(%) | 10.88 | 68.03 | 26.91 | -11.04 |
Thomas G Wiggans Ownership Network
Ownership Network List of Thomas G Wiggans
Ownership Network Relation of Thomas G Wiggans
Thomas G Wiggans Owned Company Details
What does Forma Therapeutics Holdings Inc do?
Who are the key executives at Forma Therapeutics Holdings Inc?
Thomas G Wiggans is the director of Forma Therapeutics Holdings Inc. Other key executives at Forma Therapeutics Holdings Inc include EVP & Research & Development Agustin Melian , SVP & Chief Scientific Officer David N Cook , and SVP & Chief Financial Officer Todd Shegog .
Forma Therapeutics Holdings Inc () Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Forma Therapeutics Holdings Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Forma Therapeutics Holdings Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Forma Therapeutics Holdings Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Forma Therapeutics Holdings Inc Insider Transactions
Thomas G Wiggans Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas G Wiggans. Currently GuruFocus does not have mailing address information for Thomas G Wiggans.